DSM Nutritional Products
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Forgotten F1 Teams – Series 1 Omnibus Simtek Grand Prix
Forgotten F1 Teams – Series 1 Omnibus Welcome to Forgotten F1 Teams – a mini series from Sidepodcast. These shows were originally released over seven consecutive days But are now gathered together in this omniBus edition. Simtek Grand Prix You’re listening to Sidepodcast, and this is the latest mini‐series: Forgotten F1 Teams. I think it’s proBaBly self explanatory But this is a series dedicated to profiling some of the forgotten teams. Forget aBout your Ferrari’s and your McLaren’s, what aBout those who didn’t make such an impact on the sport, But still have a story to tell? Those are the ones you’ll hear today. Thanks should go to Scott Woodwiss for suggesting the topic, and the teams, and we’ll dive right in with Simtek Grand Prix. Simtek Grand Prix was Born from Simtek Research Ltd, the name standing for Simulation Technology. The company founders were Nick Wirth and Max Mosley, Both of whom had serious pedigree within motorsport. Mosley had Been a team owner Before with March, and Wirth was a mechanical engineering student who was snapped up By March as an aerodynamicist, working underneath Adrian Newey. When March was sold to Leyton House, Mosley and Wirth? Both decided to leave, and joined forces to create Simtek. Originally, the company had a single office in Wirth’s house, But it was soon oBvious they needed a Bigger, more wind‐tunnel shaped Base, which they Built in Oxfordshire. Mosley had the connections that meant racing teams from all over the gloBe were interested in using their research technologies, But while keeping the clients satisfied, Simtek Began designing an F1 car for BMW in secret. -
Biosynthesis of Abscisic Acid by the Direct Pathway Via Ionylideneethane in a Fungus, Cercospora Cruenta
Biosci. Biotechnol. Biochem., 68 (12), 2571–2580, 2004 Biosynthesis of Abscisic Acid by the Direct Pathway via Ionylideneethane in a Fungus, Cercospora cruenta y Masahiro INOMATA,1 Nobuhiro HIRAI,2; Ryuji YOSHIDA,3 and Hajime OHIGASHI1 1Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan 2International Innovation Center, Kyoto University, Kyoto 606-8501, Japan 3Department of Agriculture Technology, Toyama Prefectural University, Toyama 939-0311, Japan Received August 11, 2004; Accepted September 12, 2004 We examined the biosynthetic pathway of abscisic Key words: Cercospora cruenta; abscisic acid; allofar- acid (ABA) after isopentenyl diphosphate in a fungus, nesene; -ionylideneethane; all-E-7,8-dihy- Cercospora cruenta. All oxygen atoms at C-1, -1, -10, and dro- -carotene -40 of ABA produced by this fungus were labeled with 18 18 O from O2. The fungus did not produce the 9Z- A sesquiterpenoid, abscisic acid (ABA, 1), is a plant carotenoid possessing -ring that is likely a precursor hormone which regulates seed dormancy and induces for the carotenoid pathway, but produced new sesqui- dehydration tolerance by reducing the stomatal aper- terpenoids, 2E,4E- -ionylideneethane and 2Z,4E- -ion- ture.1) ABA is biosynthesized by some phytopathogenic ylideneethane, along with 2E,4E,6E-allofarnesene. The fungi in addition to plants,2) but the biosynthetic origin fungus converted these sesquiterpenoids labeled with of isopentenyl diphosphate (IDP) for fungal ABA is 13C to ABA, and the incorporation ratio of 2Z,4E- - different from that for plant ABA (Fig. 1). Fungi use ionylideneethane was higher than that of 2E,4E- - IDP derived from the mevalonate pathway for ABA, ionylideneethane. -
Bioactive Compounds of Tomatoes As Health Promoters
48 Natural Bioactive Compounds from Fruits and Vegetables, 2016, Ed. 2, 48-91 CHAPTER 3 Bioactive Compounds of Tomatoes as Health Promoters José Pinela1,2, M. Beatriz P. P Oliveira2, Isabel C.F.R. Ferreira1,* 1 Mountain Research Centre (CIMO), ESA, Polytechnic Institute of Bragança, Campus de Santa Apolónia, Ap. 1172, 5301-855 Bragança, Portugal 2 REQUIMTE/LAQV, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal Abstract: Tomato (Lycopersicon esculentum Mill.) is one of the most consumed vegetables in the world and probably the most preferred garden crop. It is a key component of the Mediterranean diet, commonly associated with a reduced risk of chronic degenerative diseases. Currently there are a large number of tomato cultivars with different morphological and sensorial characteristics and tomato-based products, being major sources of nourishment for the world’s population. Its consumption brings health benefits, linked with its high levels of bioactive ingredients. The main compounds are carotenoids such as β-carotene, a precursor of vitamin A, and mostly lycopene, which is responsible for the red colour, vitamins in particular ascorbic acid and tocopherols, phenolic compounds including hydroxycinnamic acid derivatives and flavonoids, and lectins. The content of these compounds is variety dependent. Besides, unlike unripe tomatoes, which contain a high content of tomatine (glycoalkaloid) but no lycopene, ripe red tomatoes contain high amounts of lycopene and a lower quantity of glycoalkaloids. Current studies demonstrate the several benefits of these bioactive compounds, either isolated or in combined extracts, namely anticarcinogenic, cardioprotective and hepatoprotective effects among other health benefits, mainly due to its antioxidant and anti-inflammatory properties. -
FINAL -SIRS-Program-Book-2018-Online.Pdf
6th Schizophrenia International Research Society Conference Integrated Prevention and Treatment: Shifting the Way We Think FLORENCE, ITALY 4 – 8 APRIL 2018 6th Schizophrenia International Research Society Conference Integrated Prevention and Treatment: Shifting the Way We Think Opening Letter Dear Attendees, It is our great pleasure to welcome you to the 6th Biennial Schizophrenia International Research Society (SIRS) Conference. SIRS is a non-profit organization dedicated to promoting research and communication about schizophrenia among research scientists, clinicians, drug developers, and policy makers internationally. We sincerely appreciate your interest in the Society and in our conference. The fifth congress in 2016 was a major success for the field attracting more than 1800 attendees from 52 countries. We anticipate an even higher attendance at this congress with most of the best investigators in the world in attendance. SIRS was founded in 2005 with the goal of bringing together scientists from around the world to exchange the latest advances in biological and psychosocial research in schizophrenia. The Society is dedicated to facilitating international collaboration to discover the causes of, and better treatments for, schizophrenia and related disorders. Part of the mission of the Society is to promote educational programs in order to effectively disseminate new research findings and to expedite the publication of new research on schizophrenia. The focus of the 6th Biennial Conference is ‘Integrated Prevention and Treatment: Shifting the Way We Think’. Under the outstanding leadership of Program Committee Chairs, Paola Dazzan, Bita Moghaddam, and Eóin Killackey, we have an exciting scientific program planned for this year. The Program Committee selected thirty-five outstanding symposia sessions out of 103 submissions. -
Curriculum Vitae
CV – Alfred Sommer, MD, MHS 1 November 4, 2009 CURRICULUM VITAE NAME: ALFRED SOMMER, MD, MHS CITIZENSHIP: American BORN: October 2, 1942, New York, New York MARRIED: Jill Sommer CHILDREN: Charles Andrew Sommer Marni Jane Sommer PRESENT Dean Emeritus Professor, Epidemiology and International Health Johns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street, Room E6527 Baltimore, MD 21205 Telephone: 410-502-4167 Facsimile: 410-502-4169 [email protected] Professor, Ophthalmology, Wilmer Institute Johns Hopkins University School of Medicine PAST Dean, Johns Hopkins Bloomberg School of Public Health, 1990-2005 EDUCATION: MHS, Epidemiology, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland, 1973 MD, Harvard Medical School, Boston, Massachusetts, 1967 BS, Summa Cum Laude, Union College, Schenectady, New York, 1963 PROFESSIONAL TRAINING: Resident and Fellow in Ophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland, 1973-76 Fellow in Epidemiology, Johns Hopkins School of Hygiene & Public Health, Baltimore, Maryland, 1972-73 Medical Intern and Resident, Beth Israel Hospital, Harvard University, Boston, Massachusetts, 1967-69 CERTIFICATION: Diplomate, American Board of Ophthalmology, 1977 Diplomate, National Board of Medical Examiners, 1968 CV – Alfred Sommer, MD, MHS 2 HONORS: National Academy of Sciences, elected 2001 Institute of Medicine, elected 1992 Gonin Medal, International Council of Ophthalmology (and the Swiss Ophthalmological Association), 2006 Pollin Prize in Pediatric Research (Columbia University), 2004 Lucien Howe Medal, American Ophthalmological Society, 2003 Warren Alpert Research Prize (Harvard Medical School), 2003 International Duke Elder Gold Medal, International Council of Ophthalmology, 1998 Albert Lasker Clinical Medical Research Award, 1997 Helmut Horten Medical Research Award, Helmut Horten Stiftung, Switzerland, 1997 Prince Mahidol Award for International Contributions to Medicine and Public Health, Thailand, 1997 Charles A. -
2004 World Food Prize International Symposium from Asia to Africa: Rice, Biofortification, and Enhanced Nutrition October 14-15 - Des Moines, Iowa ______
2004 World Food Prize International Symposium From Asia to Africa: Rice, Biofortification, and Enhanced Nutrition October 14-15 - Des Moines, Iowa ______________________________________________________________________________ October 14, 2004 – 3:00 p.m. HIDDEN HUNGER: THE ROLE OF NUTRITION, FORTIFICATION, AND BIOFORTIFICATION Dr. Alfred Sommer Dean Johns Hopkins Bloomberg School of Public Health Good afternoon. I’m delighted to be here and given the opportunity to address this august audience. I’m going to talk a little bit differently than most of the other people have, from a clinical and a health perspective. So we’ve heard something about the role of the Rockefeller Foundation in moving forward an important agricultural agenda over the recent past. There’s also been reference made that the traditional area of interest of the Rockefeller Foundation had been in public health. And indeed the institution where I am Dean, Johns Hopkins School of Public Health, was the first school of public health founded in this country, and it was founded with support of the Rockefeller Foundation. One of the first faculty members recruited to the school was this gentleman, E.V. McCullen, who we stole away from Wisconsin where he did work on an agricultural research station. He became the first professor and chair of biochemistry at the Hopkins School of Public Health. And as many of you probably know, he is the person who first described vitamin A. This is their paper from 1913. So what goes around comes around. E.V. McCullen’s portrait hangs in our board room. Now, one of the most important early observations of the classical deficiency, the one in which most public health and clinical research is focused, up until about two decades ago, was on the very striking ocular manifestations of the deficiency. -
Read Our 2020-2021 Annual Report
2020-2021 ANNUAL REPORT TABLE OF CONTENTS LETTER FROM THE CENTER DIRECTOR ABOUT THE CENTER 3 As we eventually achieve some distance from 2020 much will be said about the extraordinary year. STRATEGIC VISION 7 Yet despite the unprecedented upheaval caused by the global COVID-19 pandemic, the TIMELINE 18 2020-21 academic year feels like the year the Johns Hopkins Cochlear Center for Hearing and Public Health really hit its stride. Our training and mentoring opportunities are NEW VENTURES 22 sought-after, and we have had exceptional cohorts of trainees. Our large epidemiological studies and clinical trials continue, with one randomized trial testing the efficacy of a RESEARCH 26 community health worker model of hearing care delivery completed this past year. And we TRAINING 32 are optimistic that this year the Food and Drug Administration will finalize their regulatory classification for over-the-counter hearing aids which were due to be released in August EVENTS 41 2020 but delayed due to the COVID-19 pandemic. FACULTY & STAFF 44 Some things remain necessarily paused: The Longitudinal Aging Study in India (LASI), National Health and Aging Trends Study (NHATS), and other large epidemiological studies where NEWS & MEDIA 57 we’ve led the addition of hearing assessments are on hold until face-to-face interactions with research participants can be restarted safely. Other studies including the ACHIEVE trial, ARIC PRESENTATIONS & PUBLICATIONS 64 study, and a study of inpatient hearing care provision at Johns Hopkins are just now resuming in-person study visits after being on pause for the past year. Some things we expanded or improved: We developed an online format for our Fellows Program in Aging, Hearing, and Public Health which is designed for overseas clinicians and researchers, and in June 2021 we will debut this program with the Latin American fellows who were accepted to last summer’s in-person program which had to be cancelled. -
Stock List Updated 28/09/2021
1:43 Formula 1 - Stock List Updated 28/09/2021 Limited Price Model Year Description Manufacturer Manuf # Edition (AUD) F o r m u l a 1 , 2 a n d 3 Alfa Romeo 158 1950 Race car (25) (Oro Series) Brumm R036 35.00 Alfa Romeo 158 1950 L.Fagioli (12) 2nd Swiss GP Brumm S055 5000 40.00 Alfa Romeo 159 1951 Consalvo Sanesi (3) 6th British GP Minichamps 400511203 55.00 Alfa Romeo Ferrari C38 2019 K.Raikkonen (7) Bahrain GP Minichamps 447190007 222 135.00 Alfa Romeo Ferrari C39 2020 K.Raikkonen (7) Turkish GP Spark S6492 100.00 Alpha Tauri Honda AT01 2020 D.Kvyat (26) Austrian GP Minichamps 417200126 400 125.00 Alpha Tauri Honda AT01 2020 P.Gasly (10) 1st Italian GP Spark S6480 105.00 Alpha Tauri Honda AT01 2020 P.Gasly (10) 7th Austrian GP Spark S6468 100.00 Andrea Moda Judd S921 1992 P.McCathy (35) DNPQ Monaco GP Spark S3899 100.00 Arrows BMW A8 1986 M.Surer (17) Belgium GP "USF&G" Last F1 race Minichamps 400860017 75.00 Arrows Mugen FA13 1992 A.Suzuki (10) "Footwork" Onyx 146 25.00 Arrows Hart FA17 1996 R. Rosset (16) European GP Onyx 284 30.00 Arrows A20 1999 T.Takagi (15) show car Minichamps 430990084 25.00 Australian GP Event car 2001 Qantas AGP Event car Minichamps AC4010300 3000 40.00 Auto Union Tipo C 1936 R.Gemellate (6) Brumm R110 38.00 BAR Supertec 01 2000 J.Villeneuve test car Minichamps 430990120 40.00 BAR Honda 03 2001 J.Villeneuve (10) Minichamps 400010010 35.00 BAR Honda 005 2003 T.Sato collection (16) Japan GP standing driver Minichamps 518034316 35.00 BAR Honda 006 2004 J. -
Multiplicity of Carotene Patterns Derives from Competition Between
www.nature.com/scientificreports OPEN Multiplicity of carotene patterns derives from competition between phytoene desaturase diversifcation and biological environments Mathieu Fournié1,2,3 & Gilles Truan1* Phytoene desaturases catalyse from two to six desaturation reactions on phytoene, generating a large diversity of molecules that can then be cyclised and produce, depending on the organism, many diferent carotenoids. We constructed a phylogenetic tree of a subset of phytoene desaturases from the CrtI family for which functional data was available. We expressed in a bacterial system eight codon optimized CrtI enzymes from diferent clades. Analysis of the phytoene desaturation reactions on crude extracts showed that three CrtI enzymes can catalyse up to six desaturations, forming tetradehydrolycopene. Kinetic data generated using a subset of fve purifed enzymes demonstrate the existence of characteristic patterns of desaturated molecules associated with various CrtI clades. The kinetic data was also analysed using a classical Michaelis–Menten kinetic model, showing that variations in the reaction rates and binding constants could explain the various carotene patterns observed. Competition between lycopene cyclase and the phytoene desaturases modifed the distribution between carotene intermediates when expressed in yeast in the context of the full β-carotene production pathway. Our results demonstrate that the desaturation patterns of carotene molecules in various biological environments cannot be fully inferred from phytoene desaturases classifcation but is governed both by evolutionary-linked variations in the desaturation rates and competition between desaturation and cyclisation steps. Carotenoids are organic pigments produced by plants, algae, fungi, and bacteria and can be subdivided into two families of molecules, carotenes and their oxidised counterparts, xanthophylls 1. -
Conversation Between Alfred Sommer, MD MHS and Daniel M. Albert, MD Chicago IL, October 15, 2010
The Foundation of the American Academy of Ophthalmology Museum of Vision & Ophthalmic Heritage Conversation Between Alfred Sommer, MD MHS and Daniel M. Albert, MD Chicago IL, October 15, 2010 Drs. Al Sommer and Dan Albert recorded this conversation on October 15, 2010 during the Annual Meeting of the American Academy of Ophthalmology, in Chicago, IL. Dr. Sommer is a glaucoma specialist from Baltimore and Dr. Albert is an ophthalmic pathologist living in Madison. You are invited now to listen to excerpts and read the complete transcript below. Here, Dr. Albert discusses why he chose to study both pathology and ophthalmology. In this excerpt, Dr. Sommer describes how he became involved with epidemiology and public health. The Foundation of the American Academy of Ophthalmology Museum of Vision & Ophthalmic Heritage Conversation Between Alfred Sommer, MD MHS and Daniel M. Albert, MD Chicago IL, October 15, 2010 ALFRED SOMMER: I’m Al Sommer, and I am 68, and I am speaking with Dan Albert. DANIEL ALBERT: I’m Dan Albert, I’m 73, and I have the pleasure of speaking with Al Sommer. AL: So, Dan, should we start off with our roots? DAN: Okay. AL: So you grew up on the other side of the river from where I was born… DAN: Right. AL: I was born in Brooklyn and you were born in…? DAN: Newark, New Jersey. AL: Did you go to public schools there or… DAN: Yes, I did. And yourself? AL: Yes, same thing. They had good public schools in those days. I went to public schools in Brooklyn and then just my last two years of high school in Queens. -
Free Radicals in Biology and Medicine Page 0
77:222 Spring 2005 Free Radicals in Biology and Medicine Page 0 This student paper was written as an assignment in the graduate course Free Radicals in Biology and Medicine (77:222, Spring 2005) offered by the Free Radical and Radiation Biology Program B-180 Med Labs The University of Iowa Iowa City, IA 52242-1181 Spring 2005 Term Instructors: GARRY R. BUETTNER, Ph.D. LARRY W. OBERLEY, Ph.D. with guest lectures from: Drs. Freya Q . Schafer, Douglas R. Spitz, and Frederick E. Domann The Fine Print: Because this is a paper written by a beginning student as an assignment, there are no guarantees that everything is absolutely correct and accurate. In view of the possibility of human error or changes in our knowledge due to continued research, neither the author nor The University of Iowa nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information. Readers are encouraged to confirm the information contained herein with other sources. All material contained in this paper is copyright of the author, or the owner of the source that the material was taken from. This work is not intended as a threat to the ownership of said copyrights. S. Jetawattana Lycopene, a powerful antioxidant 1 Lycopene, a powerful antioxidant by Suwimol Jetawattana Department of Radiation Oncology Free Radical and Radiation Biology The University -
Transcriptional Analysis of Carotenoids Accumulation and Metabolism in a Pink-Fleshed Lemon Mutant
G C A T T A C G G C A T genes Article Transcriptional Analysis of Carotenoids Accumulation and Metabolism in a Pink-Fleshed Lemon Mutant Giuseppe Lana 1 , Jaime Zacarias-Garcia 2 , Gaetano Distefano 1 , Alessandra Gentile 1, María J. Rodrigo 2 and Lorenzo Zacarias 2,* 1 Department of Agriculture, Food and Environment, University of Catania, 95123 Catania, Italy; [email protected] (G.L.); [email protected] (G.D.); [email protected] (A.G.) 2 Food Biotechnology Department, Instituto de Agroquímica y Tecnología de Alimentos, Consejo Superior de Investigaciones Científicas (IATA-CSIC), Paterna, 46980 Valencia, Spain; [email protected] (J.Z.-G.); [email protected] (M.J.R.) * Correspondence: [email protected]; Tel.: +34-963-900-022; Fax: +34-963-636-301 Received: 8 September 2020; Accepted: 28 October 2020; Published: 30 October 2020 Abstract: Pink lemon is a spontaneous bud mutation of lemon (Citrus limon, L. Burm. f) characterized by the production of pink-fleshed fruits due to an unusual accumulation of lycopene. To elucidate the genetic determinism of the altered pigmentation, comparative carotenoid profiling and transcriptional analysis of both the genes involved in carotenoid precursors and metabolism, and the proteins related to carotenoid-sequestering structures were performed in pink-fleshed lemon and its wild-type. The carotenoid profile of pink lemon pulp is characterized by an increased accumulation of linear carotenoids, such as lycopene, phytoene and phytofluene, from the early stages of development, reaching their maximum in mature green fruits. The distinctive phenotype of pink lemon is associated with an up-regulation and down-regulation of the genes upstream and downstream the lycopene cyclase, respectively.